Policy and reimbursement strategies to improve patient access to prescription digital therapeutics
Year: 2025
Type: article
Abstract: Prescription Digital Therapeutics (PDTs) deliver evidence-based treatments through FDA-cleared software. Despite demonstrated impact internationally, particularly in Germany, outdated U.S. reimbursement structures restrict access. Modernizing benefit pathways to align with the clinical rigor of PDTs can expand patient access, reduce healthcare costs, and improve outcomes. Timely action is critical to bridge care gaps, ensuring that patients receive safe, effective digital interventions supported by evidence and regulatory oversight.
Source: npj Digital Medicine
Authors: Lani Reilly, Andrew Molnar
Language: English
Subfield: Applied Psychology
Field: Psychology
Domain: Social Sciences
Open Access status: gold
Estimated APC paid: $4,090
OpenAlex ID: W4416933160
